Skip to content

13F-HR filed by SECTOR GAMMA AS

SECTOR GAMMA AS filed this 13F-HR for the quarter ended 2018-12-31, filed 2019-02-12, with 33 holding rows worth $594,735,000.

Accession
0001567619-19-003156
Filed
2019-02-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2018

A holdings report, 33 entries on the cover page, a total value of $594,735,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $594,735,000 with VALUE read as thousands by filing date, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Abbott Laboratories002824100COM897,276$64,900,000thousands by filing date
Bristol-Myers Squibb Company110122108COM1,128,470$58,658,000thousands by filing date
Boston Scientific Corporation101137107COM1,308,374$46,238,000thousands by filing date
Merck & Co.,Inc.58933Y105COM461,046$35,229,000thousands by filing date
BAXTER INTL INC071813109COM489,628$32,227,000thousands by filing date
REVVITY INC714046109COM359,081$28,206,000thousands by filing date
Gilead Sciences,Inc.375558103COM434,357$27,169,000thousands by filing date
NUVASIVE INC670704105COM473,923$23,488,000thousands by filing date
BIO RAD LABS INC090572207CL A96,697$22,455,000thousands by filing date
SHIRE PLC82481R106COMMON STOCK-FO125,656$21,869,000thousands by filing date
INCYTE CORP COM45337C102Stock336,444$21,394,000thousands by filing date
AGILENT TECHNOLOGIES INC COM00846U101Stock315,051$21,253,000thousands by filing date
IONIS PHARMACEUTICALS INC COM462222100Stock379,421$20,512,000thousands by filing date
Elevance Health, Inc.036752103COM73,513$19,307,000thousands by filing date
CVS Health Corporation126650100COM266,670$17,472,000thousands by filing date
CELGENE CORP151020104COM263,000$16,856,000thousands by filing date
QIAGEN NVN72482123SHS NEW407,406$14,035,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock306,820$11,889,000thousands by filing date
BIOGEN INC COM09062X103Stock33,100$9,960,000thousands by filing date
PATTERSON COS INC703395103COM482,263$9,481,000thousands by filing date
ALLERGAN PLCG0177J108SHS70,000$9,356,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM206,335$9,203,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock77,906$9,081,000thousands by filing date
DR REDDYS LABS LTD ADR256135203ADR171,219$6,455,000thousands by filing date
MCKESSON CORP COM58155Q103Stock56,500$6,242,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM335,577$6,027,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK862,602$5,728,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock284,701$5,557,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock268,388$4,600,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock59,437$4,334,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock240,522$3,427,000thousands by filing date
SANGAMO THERAPEUTICS INC800677106COM154,960$1,779,000thousands by filing date
ULTRAGENYX PHARMACEUTICAL IN90400D108COM8,000$348,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001567619-19-003156this filing2019-02-12acceptance time not in the bulk data set